Vol. 40 No. 2 (2023): Abril
Short Communication

Geographic distribution and type of human T-lymphotropic virus (HTLV) infection in Peruvian patients 2019-2021

Eduardo Miranda-Ulloa
Instituto Nacional de Salud - (Ministerio de salud - Perú)
Bio
Soledad Romero-Ruiz
Instituto Nacional de Salud - (Ministerio de salud - Perú)
Raul Montalvo-Otivo
Facultad de Medicina Humana, Universidad Nacional del Centro del Perú, Huancayo, Perú.
Bio
Dilan Suárez-Agüero
Instituto Nacional de Salud - (Ministerio de salud - Perú)
Bio
Hans Ramón Quiroz-Ruiz
Laboratorio de Referencia Regional de Salud Pública, Dirección Regional de Salud Cajamarca, Cajamarca, Perú.
Bio
Fanny Valverde-Ticlia
Instituto Nacional de Salud - (Ministerio de salud - Perú)
Ronal Briceño-Espinoza
Instituto Nacional de Salud - (Ministerio de salud - Perú)

Published 2023-04-28

How to Cite

1.
Miranda-Ulloa E, Romero-Ruiz S, Montalvo-Otivo R, Suárez-Agüero D, Quiroz-Ruiz HR, Valverde-Ticlia F, Briceño-Espinoza R. Geographic distribution and type of human T-lymphotropic virus (HTLV) infection in Peruvian patients 2019-2021. Rev. Chilena. Infectol. [Internet]. 2023 Apr. 28 [cited 2025 Dec. 17];40(2). Available from: https://revinf.cl/index.php/revinf/article/view/1678

Abstract

In the present study we describe and characterize the geographic distribution of HTLV-1 and 2 positive cases from Peruvian patients with presumptive diagnosis 2019 - 2021. Of a total of 555 confirmed positive samples, 546 (98.4%) were HTLV-1 and 9 (1.6%) HTLV-2. In addition, 22 of 24 departments of Peru presented cases of HTLV-1. The main reasons for requesting a confirmatory diagnosis being: aspiring to donate blood with a reactive screening test, suspicion of leukemia/ lymphoma and tropical spastic paraparesis. The results reflect that the identification of critical points constitutes a persistent gap regarding the diagnosis, being crucial to reduce the number of new cases in Peru.